-
公开(公告)号:US2967187A
公开(公告)日:1961-01-03
申请号:US78403658
申请日:1958-12-31
申请人: STANDARD OIL CO
发明人: SERRES JR CARL , FIELDS ELLIS K
-
公开(公告)号:US2920082A
公开(公告)日:1960-01-05
申请号:US73751658
申请日:1958-05-26
申请人: DOW CHEMICAL CO
发明人: ROCKLIN ALBERT L
-
-
公开(公告)号:US2871244A
公开(公告)日:1959-01-27
申请号:US51791155
申请日:1955-06-24
申请人: REYNOLDS METALS CO
发明人: JONAS KAMLET
-
公开(公告)号:US2519319A
公开(公告)日:1950-08-15
申请号:US63971046
申请日:1946-01-07
申请人: MCBEE EARL T , NEWCOMER JACK S
发明人: MCBEE EARL T , NEWCOMER JACK S
IPC分类号: C07C46/06
-
公开(公告)号:US2398418A
公开(公告)日:1946-04-16
申请号:US50028843
申请日:1943-08-27
申请人: FIESER LOUIS F
发明人: FIESER LOUIS F
IPC分类号: C07C46/00 , C07C50/02 , C07C50/10 , C07C50/14 , C07C50/24 , C07C50/28 , C07C50/32 , C07C66/00 , C07C205/46 , C07C205/48
CPC分类号: C07C66/00 , C07C46/00 , C07C50/02 , C07C50/10 , C07C50/14 , C07C50/24 , C07C50/28 , C07C50/32 , C07C201/12 , C07C205/46
-
公开(公告)号:US1826621A
公开(公告)日:1931-10-06
申请号:US40981120
申请日:1920-09-13
申请人: WILLIAM M GROSVENOR
发明人: LLOYD ELLIS A , GERSHON VICTOR P
IPC分类号: C07C46/00
-
68.
公开(公告)号:US1814147A
公开(公告)日:1931-07-14
申请号:US38451429
申请日:1929-08-08
申请人: GROGGINS PHILIP H
发明人: GROGGINS PHILIP H
IPC分类号: C07C46/00
-
-
公开(公告)号:US09932286B2
公开(公告)日:2018-04-03
申请号:US14983330
申请日:2015-12-29
IPC分类号: C07C50/38 , C07C50/04 , A61K31/05 , A61K31/355 , C07C39/08 , C07C39/11 , C07C39/19 , C07C39/24 , C07C50/02 , C07C50/06 , C07C50/24 , C07C50/28 , C07C215/56 , C07C403/04 , C07C403/08 , C07C403/18 , C07C43/225 , C07C43/23 , C07C47/277 , C07C69/608 , C07C69/618 , C07C233/27 , C07C233/32 , C07C255/37
CPC分类号: C07C50/04 , A61K31/05 , A61K31/355 , C07C39/08 , C07C39/11 , C07C39/19 , C07C39/245 , C07C43/225 , C07C43/23 , C07C47/277 , C07C50/02 , C07C50/06 , C07C50/24 , C07C50/28 , C07C69/608 , C07C69/618 , C07C215/56 , C07C233/27 , C07C233/32 , C07C255/37 , C07C403/04 , C07C403/08 , C07C403/18 , C07C2601/16
摘要: Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), or Kearns-Sayre Syndrome (KSS) are disclosed, as well as compounds useful in the methods of the invention. Methods and compounds useful in treating other disorders are also disclosed. Energy biomarkers useful in assessing the metabolic state of a subject and the efficacy of treatment are also disclosed. Methods of modulating, normalizing, or enhancing energy biomarkers, as well as compounds useful for such methods, are also disclosed.
-
-
-
-
-
-
-
-
-